PerkinElmer (PKI) Acquires BioLegend for $5.25B
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St futures muted as bond yields resume climb; Walmart drops after results
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
PerkinElmer (PKI) PT Raised to $175 at Stifel Following EPS and BioLegend Deal
July 27, 2021 6:18 AM EDTStifel analyst Daniel Arias raised the price target on PerkinElmer (NYSE: PKI) to $175.00 (from $155.00) while maintaining a Buy rating.
The analyst commented, "Yesterday, PKI announced another acquisition (the company's 7th announced since Horizon in Nov '20 - though by far the... More
PerkinElmer (PKI) Declares $0.07 Quarterly Dividend; 0.2% Yield
July 23, 2021 4:15 PM EDTPerkinElmer (NYSE: PKI) declared a quarterly dividend of $0.07 per share, or $0.28 annualized.
The dividend will be payable on November 12, 2021, to stockholders of record on October 22, 2021, with an ex-dividend date of October 21, 2021.
The annual yield on the dividend is 0.2 percent.
For a dividend... More
